|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
|
US3957965A
(en)
|
1967-08-08 |
1976-05-18 |
Fisons Limited |
Sodium chromoglycate inhalation medicament
|
|
GB1242211A
(en)
|
1967-08-08 |
1971-08-11 |
Fisons Pharmaceuticals Ltd |
Pharmaceutical composition
|
|
GB1257162A
(https=)
|
1968-02-16 |
1971-12-15 |
|
|
|
US4405598A
(en)
|
1976-01-30 |
1983-09-20 |
Fisons, Limited |
Composition for treating asthma
|
|
US4120285A
(en)
|
1976-11-01 |
1978-10-17 |
Owens-Illinois, Inc. |
Modular tubular solar energy collector apparatus
|
|
DE3104294A1
(de)
|
1981-02-07 |
1982-08-19 |
Hoechst Ag, 6000 Frankfurt |
Substituierte diazaspirodecane, ihre herstellung, ihre verwendung als stabilisatoren fuer organische polymere, sowie die so stabilisierten polymeren
|
|
US4429545A
(en)
|
1981-08-03 |
1984-02-07 |
Ocean & Atmospheric Science, Inc. |
Solar heating system
|
|
BE897058A
(fr)
|
1982-06-25 |
1983-12-16 |
Sandoz Sa |
Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
|
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
|
JPH0662601B2
(ja)
|
1985-08-16 |
1994-08-17 |
京都薬品工業株式会社 |
クロモグリク酸誘導体および抗アレルギ−剤
|
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
US4919915A
(en)
|
1987-03-03 |
1990-04-24 |
Paul Averback |
Method for detecting the ability to prevent red-to-green congophilic birefringence
|
|
WO1990013327A1
(en)
|
1989-04-28 |
1990-11-15 |
Riker Laboratories, Inc. |
Dry powder inhalation device
|
|
US5376386A
(en)
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
|
DE4405387A1
(de)
|
1994-02-19 |
1995-08-24 |
Hoechst Ag |
Verfahren zur Herstellung von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
TR199600329A2
(tr)
|
1995-05-05 |
1997-03-21 |
Hoffmann La Roche |
Seker alkollerin yeni sülfürik asit esterleri.
|
|
US6026809A
(en)
|
1996-01-25 |
2000-02-22 |
Microdose Technologies, Inc. |
Inhalation device
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
DK0999825T3
(da)
|
1997-07-29 |
2004-02-09 |
Alcon Lab Inc |
Oftalmiske sammensætninger indeholdende galactomannanpolymerer og borater
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
CN1169520C
(zh)
|
1997-09-29 |
2004-10-06 |
耐科塔医药公司 |
多孔微粒及其使用方法
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US5904937A
(en)
|
1997-10-03 |
1999-05-18 |
Fmc Corporation |
Taste masked pharmaceutical compositions
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
DK1083952T3
(da)
|
1998-06-12 |
2006-04-24 |
Microdose Technologies Inc |
Apparat til uddeling af medicinalvarer og medikamenter
|
|
US6197963B1
(en)
|
1998-08-13 |
2001-03-06 |
The Trustees Of The University Of Pennsylvania |
Non-peptide peptidomimetics
|
|
AU756852B2
(en)
|
1998-11-13 |
2003-01-23 |
Jagotec Ag |
Dry powder for inhalation
|
|
EE04996B1
(et)
|
1998-12-24 |
2008-04-15 |
Janssen Pharmaceutica N.V. |
Reguleeritud vabanemisega galantamiinipreparaat, meetod selle valmistamiseks, seda sisaldav doseerimisvorm ning farmatseutiline pakend
|
|
JP2001151673A
(ja)
|
1999-09-06 |
2001-06-05 |
Nikken Chem Co Ltd |
吸入用粉末製剤の製造方法
|
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
|
US20020107173A1
(en)
|
1999-11-04 |
2002-08-08 |
Lawrence Friedhoff |
Method of treating amyloid beta precursor disorders
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
ES2248283T3
(es)
|
2000-02-21 |
2006-03-16 |
Pharmexa A/S |
Nuevo procedimiento para reducir los niveles de amiloide.
|
|
AU5702201A
(en)
|
2000-04-13 |
2001-10-30 |
Mayo Foundation |
Abeta<sub>42</sub> lowering agents
|
|
US20080021085A1
(en)
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
|
US20020016359A1
(en)
|
2000-06-29 |
2002-02-07 |
Hellberg Mark R. |
Compositions and methods of treating neurodegenerative diseases
|
|
US8519005B2
(en)
|
2000-07-27 |
2013-08-27 |
Thomas N. Thomas |
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
|
|
FR2815030A1
(fr)
|
2000-10-05 |
2002-04-12 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
|
|
US6511960B2
(en)
|
2001-01-05 |
2003-01-28 |
Alphamed Pharmaceuticals Corp |
Cromolyn for eye and ear infections
|
|
WO2002085903A2
(en)
|
2001-04-23 |
2002-10-31 |
The Trustees Of The University Of Pennsylvania |
Amyloid plaque aggregation inhibitors and diagnostic imaging agents
|
|
AU2002352974A1
(en)
|
2001-11-29 |
2003-06-10 |
Emisphere Technologies, Inc. |
Formulations for oral administration of cromolyn sodium
|
|
PT1521609E
(pt)
|
2002-05-10 |
2010-03-03 |
Oriel Therapeutics Inc |
Inalador de pó seco para utilização com meios de distribuição accionados por um polímero piezoeléctrico e embalagem blister associada compreendendo um material polimérico piezoeléctrico
|
|
EP1601380A1
(en)
|
2003-02-13 |
2005-12-07 |
Licentia OY |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
|
|
EP1601379A1
(en)
|
2003-02-13 |
2005-12-07 |
Licentia OY |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
|
|
US20040223918A1
(en)
|
2003-05-07 |
2004-11-11 |
Chrysalis Technologies Incorporated |
Aerosolization of cromolyn sodium using a capillary aerosol generator
|
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
|
CA2534484A1
(en)
|
2003-08-07 |
2005-02-17 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes and methods for making and using same
|
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
JP4471340B2
(ja)
|
2003-10-07 |
2010-06-02 |
芦森工業株式会社 |
バックル装置
|
|
US20070053843A1
(en)
|
2003-10-28 |
2007-03-08 |
Dawson Michelle L |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
|
WO2005063732A1
(en)
|
2003-12-23 |
2005-07-14 |
Microbia, Inc. |
Compounds and methods for the treatment of asthma
|
|
WO2005077394A1
(en)
|
2004-02-11 |
2005-08-25 |
Ramot At Tel-Aviv University Ltd |
Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
|
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
|
WO2006001877A2
(en)
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
PL2708225T3
(pl)
|
2004-04-23 |
2019-07-31 |
Cydex Pharmaceuticals, Inc. |
Formulacja DPI zawierająca eter sulfoalkilowy cyklodekstryny
|
|
WO2006026555A2
(en)
|
2004-08-30 |
2006-03-09 |
Seo Hong Yoo |
Neuroprotective effect of solubilized udca in focal ischemic model
|
|
JP2008518935A
(ja)
|
2004-11-01 |
2008-06-05 |
セオ ホン ユー |
筋萎縮性側索硬化症の神経退行を減少させるための方法及び組成物
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
JP2008538767A
(ja)
|
2005-04-22 |
2008-11-06 |
ジェネンテック・インコーポレーテッド |
Ｃｄ２０抗体による認知症又はアルツハイマー病の治療方法
|
|
EP1893576A4
(en)
|
2005-05-27 |
2010-03-17 |
Univ Kingston |
TREATMENT OF PROTEIN DISORDERING
|
|
WO2007070851A2
(en)
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
|
AR059356A1
(es)
|
2006-02-14 |
2008-03-26 |
Astrazeneca Ab |
Nuevos radioligandos
|
|
EP1994011B1
(en)
|
2006-03-06 |
2010-10-13 |
RaQualia Pharma Inc |
Sulfonyl benzimidazole derivatives
|
|
EP1996175A4
(en)
|
2006-03-09 |
2009-06-10 |
Waratah Pharmaceuticals Inc |
CYCLOHEXAN POLYALKOHOL FORMULATION FOR THE TREATMENT OF PROTEIN AGGREGATION DISORDERS
|
|
US7700616B2
(en)
|
2006-05-08 |
2010-04-20 |
Molecular Neuroimaging, Llc. |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
|
US20100173960A1
(en)
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
|
US20100292157A1
(en)
|
2006-11-24 |
2010-11-18 |
Antonio Cruz |
Combination Treatments for Alzheimer's Disease and Similar Diseases
|
|
JP5675340B2
(ja)
|
2007-04-18 |
2015-02-25 |
プロビオドルグ エージー |
新規阻害剤
|
|
US20080292625A1
(en)
|
2007-04-18 |
2008-11-27 |
Sally Schroeter |
Prevention and treatment of cerebral amyloid angiopathy
|
|
WO2008134618A2
(en)
|
2007-04-27 |
2008-11-06 |
The General Hospital Corporation |
Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders
|
|
US20090110679A1
(en)
|
2007-07-13 |
2009-04-30 |
Luk-Chiu Li |
Methods and compositions for pulmonary administration of a TNFa inhibitor
|
|
GB0714134D0
(en)
|
2007-07-19 |
2007-08-29 |
Norton Healthcare Ltd |
Dry-powder medicament
|
|
PT2182983E
(pt)
|
2007-07-27 |
2014-09-01 |
Janssen Alzheimer Immunotherap |
Tratamento de doenças amiloidogénicas com anticorpos anti-abeta humanizados
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
CA2978149C
(en)
|
2008-03-21 |
2019-02-12 |
The General Hospital Corporation |
Inositol derivatives for the detection and treatment of alzheimer's disease and related disorders
|
|
EP3560496A1
(en)
|
2008-04-29 |
2019-10-30 |
Pharnext |
Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
|
|
MX2011007663A
(es)
|
2009-01-22 |
2011-08-15 |
Raqualia Pharma Inc |
Compuestos de sulfona heterociclica, saturada y sustituida en n, con actividad agonistica del receptor de cb2.
|
|
US8381454B1
(en)
|
2009-01-23 |
2013-02-26 |
Markus R. Robinson |
Segmented, elongated, expandable, 4-season, double-walled, low-cost, rigid extruded plastic panel structures
|
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
EP2391618B1
(en)
*
|
2009-01-29 |
2019-04-03 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
EP2403531A4
(en)
|
2009-03-05 |
2013-02-27 |
Abbott Lab |
IL-17 BINDING PROTEINS
|
|
AU2010224184A1
(en)
|
2009-03-11 |
2011-09-29 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of Raf kinases
|
|
US8377947B2
(en)
|
2009-03-16 |
2013-02-19 |
Chien-Hung Chen |
Treating alzheimer's disease and osteoporosis and reducing aging
|
|
ES2457442T3
(es)
|
2009-05-08 |
2014-04-25 |
Pari Pharma Gmbh |
Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
|
|
CN102573500A
(zh)
|
2009-08-06 |
2012-07-11 |
纽拉尔图斯制药公司 |
巨噬细胞相关疾病的治疗
|
|
WO2011032164A2
(en)
|
2009-09-14 |
2011-03-17 |
Kmetovicz Ronald E |
Solar heat pipe heat exchanger
|
|
DK3378856T3
(da)
|
2009-09-24 |
2020-12-21 |
Wista Lab Ltd |
Krystallinske methylthioniniumchlorid-hydrater
|
|
EP2322163A1
(en)
|
2009-11-03 |
2011-05-18 |
Pharnext |
New therapeutics approaches for treating alzheimer disease
|
|
WO2011057199A1
(en)
|
2009-11-06 |
2011-05-12 |
Adenios, Inc. |
Compositions for treating cns disorders
|
|
BR112012012999A2
(pt)
|
2009-11-30 |
2019-04-02 |
Aptalis Pharmatech, Inc. |
Composição farmacêutica, e composição de tablete de desintegração oral (odt) outablete de dispersão rápida (rdt)
|
|
US8455755B2
(en)
|
2009-12-07 |
2013-06-04 |
Electrotherm |
Concentrated photovoltaic and thermal solar energy collector
|
|
EP2377860A1
(en)
|
2010-04-16 |
2011-10-19 |
AC Immune S.A. |
Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
|
|
WO2011136754A1
(en)
|
2010-04-26 |
2011-11-03 |
Mahmut Bilgic |
A medicament developed for the treatment of respiratory diseases
|
|
US20120050049A1
(en)
*
|
2010-08-24 |
2012-03-01 |
Victor Manuel Quinones Caballero |
Safety Alarm and Method
|
|
CN103298470B
(zh)
|
2010-09-30 |
2015-06-17 |
奇斯药制品公司 |
硬脂酸镁在吸入用干粉制剂中的用途
|
|
US20120121656A1
(en)
|
2010-11-15 |
2012-05-17 |
Revalesio Corporation |
Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
|
|
EA025033B1
(ru)
|
2011-02-11 |
2016-11-30 |
Уиста Лэборэтэриз Лтд. |
Диаминиевые соли фенотиазина и их применение
|
|
US9730921B2
(en)
|
2012-03-27 |
2017-08-15 |
Duke University |
Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
|
|
AU2013266067B2
(en)
|
2012-05-25 |
2016-10-06 |
Xlear, Inc. |
Xylitol-based anti-mucosal compositions and related methods and compositions
|
|
KR20150073963A
(ko)
|
2012-10-23 |
2015-07-01 |
데이진 화-마 가부시키가이샤 |
종양 융해 증후군의 치료약 및 예방약
|
|
CA2889446C
(en)
|
2012-10-25 |
2021-05-11 |
The General Hospital Corporation |
Combination therapies for the treatment of alzheimer's disease and related disorders
|
|
US10058530B2
(en)
|
2012-10-25 |
2018-08-28 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
|
MX381503B
(es)
|
2013-05-23 |
2025-03-12 |
Aztherapies Inc |
Métodos para la liberación de cromolina.
|
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
|
AU2014340182B2
(en)
|
2013-10-22 |
2019-05-23 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
PL3104854T3
(pl)
|
2014-02-10 |
2020-11-30 |
Respivant Sciences Gmbh |
Stabilizatory komórek tucznych do leczenia choroby płuc
|
|
WO2015120389A1
(en)
|
2014-02-10 |
2015-08-13 |
Patara Pharma, LLC |
Mast cell stabilizers treatment for systemic disorders
|
|
MX2017006454A
(es)
|
2014-11-21 |
2018-03-23 |
Biohaven Pharm Holding Co Ltd |
Administracion sublingual de riluzol.
|
|
WO2016196401A1
(en)
|
2015-05-29 |
2016-12-08 |
The Texas A&M University System |
Antimicrobial and anti-inflammatory compositions
|
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
WO2017027387A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
|
EP3368032A1
(en)
|
2015-10-28 |
2018-09-05 |
AB Science |
Use of masitinib and other mast cell inhibitors for treatment of parkinson's disease
|
|
JP2018534336A
(ja)
|
2015-11-19 |
2018-11-22 |
エーゼットセラピーズ， インコーポレイテッド |
アルツハイマー病および関連障害を処置するための方法
|
|
KR20180081812A
(ko)
|
2015-11-23 |
2018-07-17 |
아즈테라피즈 인코포레이티드 |
허혈성 뇌졸중 치료용 조성물 및 방법
|
|
MX390495B
(es)
|
2016-03-25 |
2025-03-20 |
Ab Science |
Uso de masitinib para el tratamiento de una subpoblación de pacientes con esclerosis lateral amiotrófica.
|
|
CA3033079A1
(en)
|
2016-08-31 |
2018-03-08 |
The General Hospital Corporation |
Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
|
|
WO2018048989A1
(en)
|
2016-09-08 |
2018-03-15 |
Emergo Therapeutics, Inc. |
Mast cell stabilizers for treatment of hypercytokinemia and viral infection
|
|
JP7202376B2
(ja)
|
2017-07-20 |
2023-01-11 |
エーゼットセラピーズ， インコーポレイテッド |
クロモリンナトリウムおよびイブプロフェンの粉末製剤
|
|
CN108164409B
(zh)
|
2018-01-24 |
2021-06-18 |
温州医科大学 |
一种2-亚苄基-1-茚酮类似物及应用
|
|
CA3096545A1
(en)
|
2018-04-09 |
2019-10-17 |
The General Hospital Corporation |
Combination therapies for the treatment of amyotropic lateral sclerosis and related disorders
|
|
CN108403708B
(zh)
|
2018-05-22 |
2019-06-14 |
滨州医学院 |
秦皮苷在制备预防或治疗急性呼吸窘迫综合征药物中的应用
|
|
KR20210071943A
(ko)
|
2018-07-02 |
2021-06-16 |
더 제너럴 하스피탈 코포레이션 |
크로몰린 소듐 및 α-락토스의 분말화된 제형
|
|
CA3111217A1
(en)
|
2018-09-05 |
2020-03-12 |
The General Hospital Corporation |
Methods of treating cytokine release syndrome
|
|
WO2020123449A1
(en)
|
2018-12-10 |
2020-06-18 |
The General Hospital Corporation |
Cromolyn esters and uses thereof
|
|
EP4132507A4
(en)
|
2020-04-06 |
2024-05-15 |
The General Hospital Corporation |
Methods of treatment of coronavirus-induced inflammation conditions
|
|
JP2023529834A
(ja)
|
2020-06-04 |
2023-07-12 |
ザ ジェネラル ホスピタル コーポレイション |
コロナウイルス感染症を治療する方法
|
|
WO2022146914A1
(en)
|
2020-12-28 |
2022-07-07 |
The General Hospital Corporation |
Cromolyn derivatives and uses thereof
|